Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this ...

By combining proteasome inhibitors with Lys05, a drug that impairs autophagy, the team was able to shut down AML’s detour. In ...

He showed that specialized cells retain the genes to form an organism.

Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called ...

Clinical trial results have shown that an injection therapy can reduce the size of head and neck cancer tumors. Experts have ...

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

A research team from the University of Zurich and the University Children’s Hospital Zurich has developed a new approach for treating children with ...

In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.

Using spatial transcriptomics and AI, researchers redefined the mouse brain’s geography, uncovering hundreds of new ...

基因打靶（gene ...

MENLO PARK, CA, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been ...